FDA Approved Drug for Hepatitis C

The treatment armamentarium for hepatitis C has seen a recent addition - a fixed-dose combination of sofosbuvir, velpatasvir and voxilaprevir, which has been approved by the U.S. Food and Drug Administration for the treatment of chronic hepatitis C without cirrhosis or with mild cirrhosis in previously treated patients.

Related Links